|
Orwin Says Affymax Entering $2 Billion Dialysis Market - Washington Post |
Washington Post
June 27 (Bloomberg) -- John Orwin, chief executive officer of Affymax Inc., talks about the company's efforts to secure FDA approval for its first product, a drug used in the treatment of kidney dialysis patients with anemia. Orwin also discusses drug
|
|
Dialysis Patient Uses Treatment Time To Teach - LocalNews8.com |
LocalNews8.com
IDAHO FALLS, Idaho -- Having to rely on dialysis for kidney function is life-changing, as it requires dozens of hours each week spent plugged into a machine. But one Idaho Falls man has found a way to give back with the extra time.
|
|
HSE to end 'indiscriminate' transport arrangements - Irish Times |
Irish Times
THE HSE is due to publish a review later this week that is set to end “the indiscriminate arrangements” for transporting dialysis and cancer patients for treatment in the west of Ireland. The director of operations for HSE West, John Hennessy,
|
|
FDA directive on anemia drug in kidney disease patients - News-Medical.net |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
